Metraipolis › archive › dc_fa5db21741c1

The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes — Europe PMC PMID:41221687

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41221687
DOI
10.1002/cpt.70130
License (as archived)
solo-consultazione
Archived
2026-11-08T15:11:04.659Z
SHA-256 of the archived text
749edc3b93cfe7788078ab9f63efa4ef9b8783afa1d6a74386a766d1413a7e84
Stable URL of this page
https://metraipolis.com/documento/dc_fa5db21741c1

How to cite

The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes — Europe PMC PMID:41221687 — Europe PMC (en), https://europepmc.org/article/MED/41221687 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa5db21741c1 (Metraipolis archive dc_fa5db21741c1, sha256 749edc3b93cfe7788078ab9f63efa4ef9b8783afa1d6a74386a766d1413a7e84)
BibTeX
@misc{dcfa5db21741c1,
  title = {The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes — Europe PMC PMID:41221687},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41221687},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa5db21741c1; sha256 749edc3b93cfe7788078ab9f63efa4ef9b8783afa1d6a74386a766d1413a7e84},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41221687. Agents can read the archived copy with the MCP tool read_document.